Search
for
Sort by
Research 30 of 1000+
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q
- Developmental and reproductive outcome of F1 generation of Wistar rats exposed to Acanthus montanus aqueous extract during organogenesis
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Cell-free fat extract improves embryo development and clinical outcomes in older women with previous in-vitro fertilization failure
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- The Spectrum of Health Domains Important to Lupus Patients Early Development of a Disease Activity Patient Reported Outcome.
- 071 Creating Value for Psoriasis Patients: Development of a patient-driven Outcome Set for Clinical Practice
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth
- EP1410 - ECE_1202 - Individualized endocrine care in non-binary individuals: efficacy, safety, and long-term outcomes of microdosing and selective hormone modulators
- Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Development, Optimization, and In Vitro/In Vivo Evaluation of Azelaic Acid Transethosomal Gel for Antidermatophyte Activity
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Development of phage-containing hydrogel for treating Enterococcus faecalis-infected wounds
- Development and Validation of a Dermoscopic Severity Score for Female Pattern Hair Loss
- Tooth Development Associated with Mutations in Hereditary Vitamin D–Resistant Rickets
- Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings
- Wound healing: cellular mechanisms and pathological outcomes
- One Transgene: Two Outcomes
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- The tendency towards the development of psychosexual disorders in androgenetic alopecia according to the different stages of hair loss: a cross-sectional study
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- - Pregnancy and postpartum maternal hair cortisol are associated with infant development during the COVID-19 pandemic
- Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application